EFFECTS OF HMG-COA REDUCTASE INHIBITORS (ATORVASTATIN AND SIMVASTATIN) ON THE VASOACTIVE PATHWAYS MEDIATED BY ENDOTHELIN-1 AND NITRIC-OXIDEIN VASCULAR ENDOTHELIAL-CELLS
S. Lamas et al., EFFECTS OF HMG-COA REDUCTASE INHIBITORS (ATORVASTATIN AND SIMVASTATIN) ON THE VASOACTIVE PATHWAYS MEDIATED BY ENDOTHELIN-1 AND NITRIC-OXIDEIN VASCULAR ENDOTHELIAL-CELLS, Atherosclerosis, 134(1-2), 1997, pp. 243-243